Dashboard
Performance
Stock Index
Insider Buying
Sectors & Industries
Sectors
Industries
Market Overview
Home
Market Dashboard
Scan Performance
Stock Index
Insider Buying
Sectors
Industries
My Watchlist
Alpha Watchlist
How It Works
Login
Get Started
Home
IBRX
IBRX Stock Chart: Technical Analysis & Trade Ideas for ImmunityBio, Inc.
Watchlist
IBRX
🚀 📈
$BBAI
$SOUN
$RCAT
$CRWV
$SATS
$GME
$OKLO
$RKLB
$BE
Recent IBRX News
FDA Flags Anktiva Claims While ImmunityBio Pushes Regulatory Fixes
Benzinga
•
Monday, April 6, 2026
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Snowflake Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SNOW
GlobeNewswire Inc.
•
Saturday, April 4, 2026
ROSEN, THE FIRST FILING FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRX
GlobeNewswire Inc.
•
Saturday, April 4, 2026
NYSE: PINS: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against Pinterest, Inc.
GlobeNewswire Inc.
•
Friday, April 3, 2026
IBRX SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of ImmunityBio, Inc. Investors - Contact Kirby McInerney LLP by May 26, 2026
GlobeNewswire Inc.
•
Friday, April 3, 2026
ImmunityBio, Inc. (IBRX) Faces Securities Class Action Amid FDA Warning Regarding Unsupported Cancer Treatment Claims, $2 Billion Market Capitalization Wiped Out -- Hagens Berman
GlobeNewswire Inc.
•
Thursday, April 2, 2026
ImmunityBio, Inc. Securities Fraud Class Action Result of FDA Warning and 21% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
GlobeNewswire Inc.
•
Wednesday, April 1, 2026
ImmunityBio, Inc. (IBRX) Faces Securities Class Action Amid FDA Warning Regarding Unsupported Cancer Treatment Claims, $2 Billion Market Capitalization Wiped Out -- Hagens Berman
GlobeNewswire Inc.
•
Tuesday, March 31, 2026
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRX
GlobeNewswire Inc.
•
Sunday, March 29, 2026
ImmunityBio, Inc. (IBRX) Faces Securities Class Action Amid FDA Warning Regarding Unsupported Cancer Treatment Claims, $2 Billion Market Capitalization Wiped Out – Hagens Berman
GlobeNewswire Inc.
•
Friday, March 27, 2026
View More News
Technical Signal History: IBRX
ImmunityBio, Inc.
Monday, April 6, 2026
Stochastic Oscillator Bearish Cross
Stochastic Oscillator Bearish Cross
Analysis
The Strat 2 Up In Conflict
Green Day Followed by a Bullish 2-Up Breakout That Closes Red
Analysis
First Down Day After Most Up Days
First Down Day After the Longest Winning Streak
Analysis
Biggest Percent Losers
Stocks With the Biggest Losses - Bearish Momentum and Risk Signals
Analysis
Thursday, April 2, 2026
Stochastic Oscillator Bullish Cross
Stochastic Oscillator Bullish Cross
Analysis
Biggest Percent Gainers
Stocks With the Biggest Gains in a Given Period
Analysis
Wednesday, April 1, 2026
First Down Day After Most Up Days
First Down Day After the Longest Winning Streak
Analysis
Biggest Percent Losers
Stocks With the Biggest Losses - Bearish Momentum and Risk Signals
Analysis
Tuesday, March 31, 2026
The Strat 2 Up Reversal
Red Day Followed by a Bullish 2-Up Breakout That Closes Green
Analysis
UT Bot Buy Signal After Biggest Pullback
First UT Bot Buy Signal After the Biggest Percent Pullback
Analysis
First UT Bot Buy Signal After Most Down Days
First UT Bot Buy Signal After the Longest Sell Streak
Analysis
Biggest Percent Gainers
Stocks With the Biggest Gains in a Given Period
Analysis
Monday, March 30, 2026
MACD Crossed Below 0
MACD Crossing Below Zero After an Extended Run Above
Analysis
The Strat 2 Down
Green Day Followed by a Bearish 2-Down Breakout That Closes Red
Analysis
First Down Day After Most Up Days
First Down Day After the Longest Winning Streak
Analysis
Biggest Percent Losers
Stocks With the Biggest Losses - Bearish Momentum and Risk Signals
Analysis
Friday, March 27, 2026
The Strat 2 Down In Conflict
Red Day Followed by a Bearish 2-Down Breakout That Closes Green
Analysis
Thursday, March 26, 2026
Stochastic Oscillator Bearish Cross
Stochastic Oscillator Bearish Cross
Analysis
First Down Day After Most Up Days
First Down Day After the Longest Winning Streak
Analysis
Biggest Percent Losers
Stocks With the Biggest Losses - Bearish Momentum and Risk Signals
Analysis